Rationale for suppression of adrenal steroidogenesis in advanced prostatic cancer.
D000305:Adrenal Cortex Hormones / Q000096:biosynthesis*; D000616:Aminoglutethimide / Q000378:metabolism / Q000627:therapeutic use*; D000726:Androgen Antagonists / Q000627:therapeutic use*; D000728:Androgens / Q000096:biosynthesis* / Q000097:blood; D000818:Animals; D004967:Estrogens / Q000096:biosynthesis; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D051381:Rats; D011944:Receptors, Androgen / Q000502:physiology
D000305:Adrenal Cortex Hormones; D000726:Androgen Antagonists; D000728:Androgens; D004967:Estrogens; D011944:Receptors, Androgen; D000616:Aminoglutethimide